Korean 
Procalcitonin (PCT) is more than just a biomarker, it’s a breakthrough tool in the world of in vitro diagnostics (IVD). Its role in identifying and managing bacterial infections and sepsis is reshaping clinical decision-making, offering:
PCT is a highly reliable marker for detecting and monitoring bacterial infections and sepsis, helping healthcare providers:
✔️ Differentiate bacterial from viral infections
✔️ Guide antibiotic therapy decisions
✔️ Monitor disease progression and treatment response
As healthcare systems strive for precision and efficiency, PCT-based diagnostics empower providers with actionable insights that save lives and reduce healthcare costs. It’s a prime example of how innovation meets impact in modern medicine.
